What's breaking now, across thousands of outlets.
Analysts guessed that investors wanted to see stronger durability results at a four-year check-in of the key trial supporting a potential approval of "AMT-130."
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Gene Solutions, a global biotechnology company providing precision cell-free DNA solutions through multi-omics ...
[Nile Post] Prevent! Recognise! Respond! Save lives
The World Health Organisation (WHO) has pledged to strengthen its support for healthcare delivery in the Upper East Region, with a focus on vulnerable populations and the health challenges associated…
Robert Hunter will focus on UnitedHealthcare’s “modernization agenda” in the new role. It’s the latest in a slew of leadership changes at UnitedHealth as the company works to restore its image.
The Federal Capital Territory Administration (FCTA) is has approved the immediate renovation, rehabilitation and upgrading of all general hospitals (14) in the territory, with new medical equipment…
Globally, about two in three people will need major surgery at some point in their lives.
